Browse Careers
Browse Investors

Court Rules in Favor of Bard on Patent Infringement Suit against W. L. Gore & Associates

MURRAY HILL, N.J., Jul 30, 2008 (BUSINESS WIRE) -- C. R. Bard, Inc. (NYSE: BCR) today announced that a U.S. District Court in Arizona entered judgment in Bard's favor in its patent infringement suit against W. L. Gore & Associates. The Court ruled that Gore failed to prove that Bard's patent number 6,436,135 was unenforceable due to inequitable conduct. As previously announced, on December 11, 2007, a jury found that Gore willfully infringed Bard's patent through the sale of Gore's ePTFE vascular grafts and stent-grafts, and awarded Bard $185 million in past damages.

Gore may file post-trial motions with the court and may appeal the judgment to the Court of Appeals for the Federal Circuit.

C. R. Bard, Inc., ( headquartered in Murray Hill, N.J., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current expectations, the accuracy of which is necessarily subject to risks and uncertainties. These statements are not historical in nature and use words such as "anticipate", "estimate", "expect", "project", "intend", "forecast", "plan", "believe", and other words of similar meaning in connection with any discussion of future operating or financial performance. Many factors may cause actual results to differ materially from anticipated results including product developments, sales efforts, income tax matters, the outcomes of contingencies such as legal proceedings, and other economic, business, competitive and regulatory factors. The company undertakes no obligation to update its forward-looking statements. Please refer to the Cautionary Statement Regarding Forward-Looking Information in our June 30, 2008 Form 10-Q for more detailed information about these and other factors that may cause actual results to differ materially from those expressed or implied..

SOURCE: C. R. Bard, Inc.

C. R. Bard, Inc.
Investor Relations:
Eric J. Shick, 908-277-8413
Vice President, Investor Relations
Media Relations:
Holly P. Glass, 703-754-2848
Vice President, Government and Public Relations


Primary Media Relations Contact

Scott Lowry
Vice President and Treasurer
C. R. Bard, Inc.
730 Central Avenue
Murray Hill, NJ 07974

Tel: 908-277-8365